FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym Active Case insensitive SNOMED CT model component
900000000001067014 Concept inactivation indicator reference set en Synonym Active Case insensitive SNOMED CT model component
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Case insensitive SNOMED CT model component


141150 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members conceptInactivationValue
pT2 (II): Tumour confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) Outdated
pT2 (II): Tumour extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) Outdated
pT2 (II): Tumour invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) Outdated
pT2 (II): Tumour invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) Outdated
pT2 (II): Tumour involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) Outdated
pT2 (II): Tumour involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) Outdated
pT2 category Outdated
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) Outdated
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) Outdated
pT2: Organ confined (prostate) Outdated
pT2: Solitary tumour with vascular invasion or multiple tumours none more than 5 cm (liver, including intrahepatic bile ducts) Outdated
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) Outdated
pT2: Tumour confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) Outdated
pT2: Tumour extends to the soft tissues (nasopharynx) Outdated
pT2: Tumour extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) Outdated
pT2: Tumour extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) Outdated
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) Outdated
pT2: Tumour invades beyond the wall of bile duct (extrahepatic bile ducts) Outdated
pT2: Tumour invades duodenal wall (ampulla of Vater) Outdated
pT2: Tumour invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) Outdated
pT2: Tumour invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx Outdated
pT2: Tumour invades muscularis (renal pelvis and ureter) Outdated
pT2: Tumour invades muscularis propria (appendix) Outdated
pT2: Tumour invades muscularis propria (colon/rectum) Outdated
pT2: Tumour invades muscularis propria (oesophagus) Outdated
pT2: Tumour invades muscularis propria (small intestine) Outdated
pT2: Tumour invades muscularis propria (urinary bladder, ureter, renal pelvis) Outdated
pT2: Tumor invades muscularis propria or subserosa (stomach) Outdated
pT2: Tumour invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) Outdated
pT2: Tumour invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) Outdated
pT2: Tumour involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumour (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) Outdated
pT2: Tumour limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) Outdated
pT2: Tumour limited to the testis and epididymis with vascular/lymphatic invasion, or tumour extending through the tunica albuginea with involvement of the tunica vaginalis (testis) Outdated
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) Outdated
pT2: Tumour more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) Outdated
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) Outdated
pT2: Tumour more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) Outdated
pT2: Tumour more than 2 cm but not more than 5 cm in greatest dimension (anal canal) Outdated
pT2: Tumour more than 2 cm but not more than 5 cm in greatest dimension (breast) Outdated
pT2: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) Outdated
pT2: Tumour more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) Outdated
pT2: Tumour more than 7 cm in greatest dimension, limited to the kidney (kidney) Outdated
pT2: Tumour more than 8 cm in greatest dimension (bone) Outdated
pT2: Tumour more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumour/Ewing's sarcoma) Outdated
pT2: Tumour of lung as per AJCC 6th Edition definition (lung) Outdated
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) Outdated
pT2a (IIA): Tumour involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) Outdated
pT2a (IIA): Tumour limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) Outdated
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) Outdated
pT2a category Outdated
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) Outdated
pT2a: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) Outdated
pT2a: Tumour confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) Outdated
pT2a: Tumour extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) Outdated
pT2a: Tumour invades muscularis propria (stomach) Outdated
pT2a: Tumour invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) Outdated
pT2a: Tumour invades superficial muscle (inner half) (urinary bladder) Outdated
pT2a: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) Outdated
pT2a: Tumour more than 5 cm in greatest dimension, superficial tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) Outdated
pT2a: Tumour more than 5 cm in greatest dimension, superficial tumour (soft tissue) Outdated
pT2a: Unilateral, one-half of one lobe or less (prostate) Outdated
pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) Outdated
pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) Outdated
pT2b (IIB): Tumour involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) Outdated
pT2b (IIB): Tumour with parametrial invasion (TNM category and FIGO stage) (uterine cervix) Outdated
pT2b category Outdated
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) Outdated
pT2b: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) Outdated
pT2b: Tumour extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) Outdated
pT2b: Tumour invades choroid focally (retinoblastoma) Outdated
pT2b: Tumour invades deep muscle (outer half) (urinary bladder) Outdated
pT2b: Tumour invades subserosa (stomach) Outdated
pT2b: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) Outdated
pT2b: Tumour more than 5 cm in greatest dimension, deep tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) Outdated
pT2b: Tumour more than 5 cm in greatest dimension, deep tumour (soft tissue) Outdated
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) Outdated
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) Outdated
pT2c (IIC): Tumour involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) Outdated
pT2c category Outdated
pT2c: Bilateral disease (prostate) Outdated
pT2c: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) Outdated
pT2c: Tumour invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) Outdated
pT2c: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) Outdated
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) Outdated
pT3 (III): Tumour extends to pelvic wall (TNM category and FIGO stage) (vagina) Outdated
pT3 (III): Tumour extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) Outdated
pT3 (III): Tumour involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) Outdated
pT3 (III): Tumour of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) Outdated
pT3 and/or N1 (III): Tumour involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) Outdated
pT3 and/or N1 (III): Tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) Outdated
pT3 category Outdated
pT3: Discontinuous tumours in the primary bone site (bone) Outdated
pT3: Discontinuous tumours in the primary bone site (osseous primitive neuroectodermal tumour/Ewing's sarcoma) Outdated
pT3: Extraprostatic extension (prostate) Outdated
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) Outdated
pT3: Multiple tumours more than 5 cm or tumour involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) Outdated
pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) Outdated
pT3: Tumour confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) Outdated
pT3: Tumour extends beyond the pancreas but without involvement of the coeliac axis or the superior mesenteric artery (exocrine pancreas) Outdated
pT3: Tumour extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) Outdated
pT3: Tumour extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) Outdated

Start Previous Page 1406 of 1412 Next End


Reference Sets

Reference set descriptor

Back to Start